Literature DB >> 11326230

Cellular therapy reverses myocardial dysfunction.

C Rajnoch1, J C Chachques, A Berrebi, P Bruneval, M O Benoit, A Carpentier.   

Abstract

OBJECTIVES: Cellular cardiomyoplasty refers to the implantation of autologous skeletal muscle cells into the myocardium to reinforce its structure and function. In this study a reproducible method for the creation of a myocardial lesion was developed. The functional benefit of cell implantation was evaluated by 2-dimensional echocardiography for global contraction and color kinesis echocardiography, which allows the precise assessment of the regional contraction.
METHODS: A left ventricular intramyocardial injection with snake cardiotoxin was carried out on a sheep model to induce a well-delineated transmural lesion. Three weeks later, the lesion was assessed by echocardiography. Thereafter, autologous skeletal muscle cells or culture media (control) were injected into the lesion. Two months after cell implantation, the myocardial contraction was again evaluated by echocardiography and the implanted cells were analyzed by a fast myosin heavy chain antibody.
RESULTS: 1. The snake cardiotoxin produced a well-delineated transmural lesion in all animals. 2. Echocardiographic studies showed a significant improvement in global and regional left ventricular function in cell-treated sheep. 3. Histologic analyses demonstrated satellite cell survival at the periphery of the lesions.
CONCLUSION: Satellite cells implanted in a cardiotoxin-induced myocardial lesion survived for a 2-month period and were associated with a significant functional improvement of both local and global contraction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326230     DOI: 10.1067/mtc.2001.112937

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host.

Authors:  Bertrand Leobon; Isabelle Garcin; Philippe Menasche; Jean-Thomas Vilquin; Etienne Audinat; Serge Charpak
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205

Review 2.  Current clinical perspectives on myocardial angiogenesis.

Authors:  Debabrata Mukherjee
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 3.  Cell transplantation in non-ischemic dilated cardiomyopathy. A novel biological approach for ventricular restoration.

Authors:  Nobuhisa Ohno; Paul W M Fedak; Richard D Weisel; Masashi Komeda; Donald A G Mickle; Ren-Ke Li
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-11

Review 4.  Review of stem cell-based therapy for the treatment of cardiovascular disease.

Authors:  Cindy M Martin
Journal:  J Cardiovasc Transl Res       Date:  2008-04-22       Impact factor: 4.132

Review 5.  Myoblast-based cell transplantation.

Authors:  Philippe Menasché
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 6.  Cell therapy in congestive heart failure.

Authors:  Ze-wei Tao; Long-gui Li
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

Review 7.  Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair.

Authors:  Narmeen Hassan; Jason Tchao; Kimimasa Tobita
Journal:  Stem Cells Transl Med       Date:  2013-12-26       Impact factor: 6.940

8.  Development of bioartificial myocardium using stem cells and nanobiotechnology templates.

Authors:  Juan Carlos Chachques
Journal:  Cardiol Res Pract       Date:  2010-12-29       Impact factor: 1.866

Review 9.  Biomaterial strategies for alleviation of myocardial infarction.

Authors:  Jayarama Reddy Venugopal; Molamma P Prabhakaran; Shayanti Mukherjee; Rajeswari Ravichandran; Kai Dan; Seeram Ramakrishna
Journal:  J R Soc Interface       Date:  2011-09-07       Impact factor: 4.118

10.  Enhancing repair of the mammalian heart.

Authors:  Maria Paola Santini; Lana Tsao; Laurent Monassier; Catherine Theodoropoulos; Janice Carter; Enrique Lara-Pezzi; Esfir Slonimsky; Ekaterina Salimova; Patrice Delafontaine; Yao-Hua Song; Martin Bergmann; Christian Freund; Ken Suzuki; Nadia Rosenthal
Journal:  Circ Res       Date:  2007-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.